Cardiac Success Featured at THT 2023 Conference (Technologies and Heart Failure Therapeutics) in Boston.
The Vsling stood out as a pioneering technology in the heart failure arena. Esteemed speakers, including Dr. Gregg W. Stone, Dr. Horst Sievert, and our CEO, Mr. Boaz Manash, presented our technology, highlighting its potential to revolutionize heartfailure treatment.
Cardiac Success Awarded €10M in Grants and Equity Investment from the European Innovation Council
Funds to accelerate the clinical development of the novel “V-sling” system, a transcatheter ventricular repair implant designed to provide a new therapy for heart failure patients.
Israeli Medical Device Startup, Cardiac Success Ltd., Closes US $5.2M Series A Financing.
The round was led by 415 CAPITAL, a specialist medical technology venture capital firm who was joined by an unnamed strategic investor and global leader in structural heart interventions…
